Bioorganic and Medicinal Chemistry Letters p. 3181 - 3186 (2007)
Update date:2022-08-04
Topics: Benzimidazole
Hirashima, Shintaro
Oka, Takahiro
Ikegashira, Kazutaka
Noji, Satoru
Yamanaka, Hiroshi
Hara, Yoshinori
Goto, Hiroyuki
Mizojiri, Ryo
Niwa, Yasushi
Noguchi, Toru
Ando, Izuru
Ikeda, Satoru
Hashimoto, Hiromasa
Following the discovery of JTK-109 (1) as a potent inhibitor of hepatitis C virus NS5B RNA-dependent RNA polymerase, [(a) Hirashima, S.; Suzuki, T.; Ishida, T.; Noji, S.; Yata, S.; Ando, I.; Komatsu, M.; Ikeda, S.; Hashimoto, H. J. Med. Chem. 2006, 49, 4721. (b) Hashimoto, H.; Mizutani, K.; Yoshida, A. Int. Patent Appl. WO 01/47883, 2001.] further studies toward the improvement of the cellular potency have been performed. A greater than 40-fold improvement was achieved through replacing the biphenyl moiety with a 2-morpholinophenyl group and the benzimidazole ring with the tetracyclic scaffold to afford compound 7 with an excellent replicon potency (EC50 = 7.6 nM).
View MoreContact:86-21-34622192,13917187091,21-34622765
Address:No. 500 Caobao Road Shanghai P.R China
website:http://www.alwaychem.com
Contact:+86-532-8586-4000, 8586-5000
Address:NO.51, TAIPING ROAD, QINGDAO, CHINA. 266001
Contact:86+21-56421993
Address:3F,BUILDING 10,NO.2889 JINKE ROAD, SHANGHAI.
Anhui Qingyun Pharmaceutical and Chemical Co.,Ltd
Contact:+86-551-63633067
Address:Shuangfeng Road Hefei Anhui
chengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Doi:10.1016/j.jorganchem.2004.09.036
(2005)Doi:10.1007/BF00770311
(1982)Doi:10.1016/j.tetlet.2004.12.014
(2005)Doi:10.1016/j.bmc.2004.10.053
(2005)Doi:10.1055/s-0036-1588103
(2017)Doi:10.1021/jo048106q
(2005)